title: Application of mupirocin cream at the catheter exit site reduces exit-site infections and peritonitis in peritoneal dialysis patients.
authors: Section on Nephrology, Wake Forest University School of Medicine, and Piedmont Dialysis Center, Inc., Winston-Salem, North Carolina, USA. mjcasey@wfubmc.edu
authors: M
authors: M
authors: Casey
authors: J
authors: J
authors: Taylor
authors: P
authors: P
authors: Clinard
authors: A
authors: A
authors: Graham
authors: V
authors: V
authors: Mauck
authors: L
authors: L
authors: Spainhour
authors: P
authors: P
authors: Brown
authors: J
authors: J
authors: Burkart
mesh_terms: D000287:Administration, Topical; D000328:Adult; D000368:Aged; D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D001424:Bacterial Infections / Q000188:drug therapy* / Q000209:etiology / Q000517:prevention & control; D002408:Catheters, Indwelling; D004655:Emulsions; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D016712:Mupirocin / Q000008:administration & dosage*; D010530:Peritoneal Dialysis / Q000009:adverse effects*; D010538:Peritonitis / Q000188:drug therapy* / Q000209:etiology / Q000517:prevention & control; D012016:Reference Values; D016896:Treatment Outcome
chemical_list: D000900:Anti-Bacterial Agents; D004655:Emulsions; D016712:Mupirocin